NDC 55513-192

Neulasta

Pegfilgrastim

Neulasta is a Subcutaneous Kit in the Human Prescription Drug category. It is labeled and distributed by Amgen Inc. The primary component is .

• Product ID: 55513-192_1ca38d81-c6b9-4a90-97d3-35089b4aba67
• NDC: 55513-192
• Product Type: Human Prescription Drug
• Proprietary Name: Neulasta
• Generic Name: Pegfilgrastim
• Dosage Form: Kit
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2002-04-01
• Marketing Category: BLA / BLA
• Application Number: BLA125031
• Labeler Name: Amgen Inc
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 55513-192-01

1 KIT in 1 CARTON (55513-192-01) * .6 mL in 1 SYRINGE

• Marketing Start Date: 2015-02-20
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 55513-192-01 [55513019201]

Neulasta KIT

• Marketing Category: BLA
• Application Number: BLA125031
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2015-02-20

Drug Details

NDC Crossover Matching brand name "Neulasta" or generic name "Pegfilgrastim"

NDC	Brand Name	Generic Name
55513-190	Neulasta	pegfilgrastim
55513-192	Neulasta	pegfilgrastim
67457-833	Fulphila	pegfilgrastim
70121-1627	FYLNETRA	pegfilgrastim